brodalumab
Showing 1 - 16 of 16
Hidradenitis Suppurativa, Acne Inversa Trial in New York (Brodalumab)
Completed
- Hidradenitis Suppurativa
- Acne Inversa
- Brodalumab
-
New York, New YorkThe Rockefeller University
Jul 26, 2022
Brodalumab in Psoriasis Inadequate Response to Their Current
Completed
- Psoriasis
- Brodalumab
-
Nanaimo, British Columbia, Canada
- +10 more
Jul 13, 2022
Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)
Recruiting
- Psoriasis
- Brodalumab
- +2 more
-
Brussels, Bruxelles-Capitale, Belgium
- +21 more
Jan 27, 2023
Psoriasis Trial in Bridgewater (Brodalumab, Comparator Drug (non-biologic IL-17 inhibitors))
Enrolling by invitation
- Psoriasis
- Brodalumab
- Comparator Drug (non-biologic IL-17 inhibitors)
-
Bridgewater, New JerseyRegistry
Dec 14, 2021
Molecular Signatures in Inflammatory Skin Disease
Recruiting
- Atopic Dermatitis
- Psoriasis
- Ustekinumab
- +9 more
-
Kiel, GermanyDepartment of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022
Hidradenitis Suppurativa Trial in New York (Brodalumab)
Withdrawn
- Hidradenitis Suppurativa
- Brodalumab
-
New York, New YorkRockefeller University Hospital
Sep 2, 2020
Hidradenitis Suppurativa Trial in New York (Brodalumab)
Completed
- Hidradenitis Suppurativa
- Brodalumab
-
New York, New YorkRockefeller Unviersity
Jun 3, 2020
Psoriasis Trial in Aarhus (Brodalumab, Placebos)
Unknown status
- Psoriasis
- Brodalumab
- Placebos
-
Aarhus, DenmarkAarhus University Hospital
Jul 9, 2019
Psoriasis Vulgaris Trial in Germany (Brodalumab, Fumaric acid esters)
Completed
- Psoriasis Vulgaris
- Brodalumab
- Fumaric acid esters
-
Bad Bentheim, Germany
- +29 more
Feb 10, 2020
Hidradenitis Suppurativa Trial in Coral Gables (Brodalumab)
Unknown status
- Hidradenitis Suppurativa
- Brodalumab
-
Coral Gables, FloridaFlorida Academic Centers Research and Education, LLC
Apr 9, 2019